The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...